Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD

NCT05624268 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

255

Enrollment

INDUSTRY

Sponsor class

Conditions

Treatment Resistant Depression

Interventions

DRUG: Psilocybin

Sponsor

COMPASS Pathways